The question over whether the NIH funded risky gain-of-function research in Wuhan, China was officially 'answered' last week, after the agency claimed that one of their partners - EcoHealth Alliance, failed to report that they had 'accidentally' created a chimeric coronavirus that was able to infect humanized mice.

To review, in a Wednesday letter addressed to Rep. James Comer (R-KY), NIH Principal Deputy Director Lawrence A. Tabak admits to funding a "limited experiment" to determine whether "spike proteins from naturally occurring bat coronaviruses circulating in China were capable of binding to the human ACE2 receptor in a mouse model." According to the letter, humanized mice infected with the modified bat virus "became sicker" than those exposed to an unmodified version of the same bat coronavirus.